Rocket Pharmaceuticals, Inc. (RCKT)
3.665
-0.12
(-3.04%)
USD |
NASDAQ |
Aug 26, 16:00
3.665
0.00 (0.00%)
After-Hours: 20:00
Rocket Pharmaceuticals Total Liabilities (Quarterly) : 54.27M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 54.27M |
| March 31, 2026 | 47.37M |
| December 31, 2025 | 53.23M |
| September 30, 2025 | 54.36M |
| June 30, 2025 | 66.77M |
| March 31, 2025 | 58.93M |
| December 31, 2024 | 64.47M |
| September 30, 2024 | 63.92M |
| June 30, 2024 | 61.78M |
| March 31, 2024 | 57.94M |
| December 31, 2023 | 73.77M |
| September 30, 2023 | 57.68M |
| June 30, 2023 | 58.81M |
| March 31, 2023 | 55.88M |
| December 31, 2022 | 62.12M |
| September 30, 2022 | 49.95M |
| June 30, 2022 | 44.16M |
| March 31, 2022 | 42.53M |
| December 31, 2021 | 42.30M |
| September 30, 2021 | 44.58M |
| June 30, 2021 | 45.72M |
| March 31, 2021 | 96.48M |
| December 31, 2020 | 87.30M |
| September 30, 2020 | 93.66M |
| June 30, 2020 | 86.54M |
| Date | Value |
|---|---|
| March 31, 2020 | 86.70M |
| December 31, 2019 | 64.82M |
| September 30, 2019 | 67.99M |
| June 30, 2019 | 60.22M |
| March 31, 2019 | 65.06M |
| December 31, 2018 | 57.28M |
| September 30, 2018 | 51.36M |
| June 30, 2018 | 50.50M |
| March 31, 2018 | 47.02M |
| December 31, 2017 | 4.628M |
| September 30, 2017 | 53.58M |
| June 30, 2017 | 53.54M |
| March 31, 2017 | 54.66M |
| December 31, 2016 | 56.48M |
| September 30, 2016 | 55.08M |
| June 30, 2016 | 4.407M |
| March 31, 2016 | 4.965M |
| December 31, 2015 | 4.508M |
| September 30, 2015 | 3.649M |
| June 30, 2015 | 19.97M |
| March 31, 2015 | 21.57M |
| December 31, 2014 | 10.28M |
| September 30, 2014 | 9.108M |
| June 30, 2014 | |
| March 31, 2014 |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 1.646B |
| Oncolytics Biotech, Inc. | 13.84M |
| Sangamo Therapeutics, Inc. | 78.92M |
| Sarepta Therapeutics, Inc. | 1.661B |
| Anixa Biosciences, Inc. | 1.641M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 423.10M |
| Shareholders Equity (Quarterly) | 368.83M |
| Debt to Equity Ratio | 0.0672 |
| Current Ratio | 9.245 |
| Net Debt Paydown Yield | 0.03% |